AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1696418 — intervention group
Group type: COMPARATOR
Intervention: Preparatory information without video (n = 34)
Number of subjects: 60
Study 1696418 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparatory information with video (n = 26)
Number of subjects: 60
Study 7295489 — intervention group
Group type: EXPERIMENTAL
Intervention: Diacetolol 100 mg
Number of subjects: 5
Study 7295489 — intervention group
Group type: EXPERIMENTAL
Intervention: Diacetolol 200 mg
Number of subjects: 5
Study 7295489 — intervention group
Group type: EXPERIMENTAL
Intervention: Diacetolol 400 mg
Number of subjects: 5
Study 7295489 — intervention group
Group type: EXPERIMENTAL
Intervention: Diacetolol 800 mg
Number of subjects: 5
Study 7295489 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 30173193 — intervention group
Group type: EXPERIMENTAL
Intervention: Camera-supervised OSCE
Number of subjects: 32
Study 30173193 — intervention group
Group type: COMPARATOR
Intervention: Direct observation OSCE
Number of subjects: 32
Study 26746199 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-care F(−) treatment (FD) - 1,100 ppm F(−) dentifrice, 2x1 min/day
Number of subjects: 12
Study 26746199 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional fluoride treatment (FVD) - 22,600 ppm F(−) varnish plus FD
Number of subjects: 12
Study 26746199 — intervention group
Group type: COMPARATOR
Intervention: Control (C) - saliva
Number of subjects: 12
Study 26746199 — intervention group
Group type: EXPERIMENTAL
Intervention: TEMDP lesion
Number of subjects: 12
Study 26746199 — intervention group
Group type: EXPERIMENTAL
Intervention: General response to fluoride treatments
Number of subjects: 12
Study 26746199 — intervention group
Group type: EXPERIMENTAL
Intervention: TMR measurements
Number of subjects: 12
Study 24284438 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity behavioral intervention targeting gestational weight gain, healthy eating, and exercise (discontinued at delivery)
Number of subjects: 401
Study 23796570 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical pressure attenuation device
Number of subjects: 166
Study 23796570 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 166
Study 20152345 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal drainage (PD)
Number of subjects: 69
Study 20152345 — intervention group
Group type: COMPARATOR
Intervention: Laparotomy (LAP)
Number of subjects: 69
Study 18539672 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopically- and fluoroscopically-assisted reduction and external fixation plus percutaneous pinning
Number of subjects: 20
Study 18539672 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopically-assisted reduction alone and external fixation plus percutaneous pinning
Number of subjects: 20
Study 16524439 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchial challenge with capsaicin
Number of subjects: 21
Study 16524439 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe symptoms to perfume (n=11)
Number of subjects: 21
Study 16524439 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 21
Study 15025702 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand dishwashing liquid 1
Number of subjects: 30
Study 15025702 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand dishwashing liquid 2
Number of subjects: 30
Study 15025702 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm immersion test
Number of subjects: 30
Study 15025702 — intervention group
Group type: COMPARATOR
Intervention: Intact skin capacitance
Number of subjects: 30
Study 11099368 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental drink (SD; isocaloric and isonitrogenous to WF)
Number of subjects: 10
Study 11099368 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage (P)
Number of subjects: 10
Study 11099368 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole food (WF: protein 38 g; carbohydrate 70 g; fat 7 g)
Number of subjects: 10
Study 11099368 — intervention group
Group type: EXPERIMENTAL
Intervention: Isocaloric carbohydrate beverage (C)
Number of subjects: 10
Study 11099368 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol
Number of subjects: 10
Study 8603220 — intervention group
Group type: EXPERIMENTAL
Intervention: 12% sucrose solution
Number of subjects: 285
Study 8603220 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterile water
Number of subjects: 285
Study 8603220 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 285
Study 1411702 — intervention group
Group type: EXPERIMENTAL
Intervention: High qualification with mention of disability
Number of subjects: 2228
Study 1411702 — intervention group
Group type: EXPERIMENTAL
Intervention: Low qualification with mention of disability
Number of subjects: 2228
Study 1411702 — intervention group
Group type: COMPARATOR
Intervention: High qualification without mention of disability
Number of subjects: 2228
Study 1411702 — intervention group
Group type: COMPARATOR
Intervention: Low qualification without mention of disability
Number of subjects: 2228
Study 3880819 — intervention group
Group type: EXPERIMENTAL
Intervention: Netilmicin
Number of subjects: 3
Study 3880819 — intervention group
Group type: EXPERIMENTAL
Intervention: Amikacin
Number of subjects: 3
Study 3880819 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 3
Study 3880819 — intervention group
Group type: EXPERIMENTAL
Intervention: Netilmicin or Amikacin
Number of subjects: 3
Study 31298158 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-based anesthesia
Number of subjects: 8000
Study 31298158 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane-based anesthesia
Number of subjects: 8000
Study 30060746 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Grains (WG)
Number of subjects: 49
Study 30060746 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruits and Vegetables (FV)
Number of subjects: 49
Study 30060746 — intervention group
Group type: COMPARATOR
Intervention: Control (Refined Grains)
Number of subjects: 49
Study 27088994 — intervention group
Group type: EXPERIMENTAL
Intervention: CSE with EVE of 10 mL normal saline
Number of subjects: 60
Study 27088994 — intervention group
Group type: COMPARATOR
Intervention: CSE NEVE
Number of subjects: 60
Study 24219166 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine-naloxone treatment for 12 weeks
Number of subjects: 360
Study 21710292 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Water Immersion (CWI)
Number of subjects: 18
Study 21710292 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast Water Immersion (CWT)
Number of subjects: 18
Study 20167897 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group 1 (specific intervention not detailed)
Number of subjects: 36
Study 20167897 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group 2 (specific intervention not detailed)
Number of subjects: 36
Study 20167897 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group 3 (specific intervention not detailed)
Number of subjects: 36
Study 20167897 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group 1, 2, or 3 (specific intervention not detailed)
Number of subjects: 36
Study 18401195 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation 3 times a week for 1 month, using a custom-made device generating direct and alternative current in 10-200 Hz frequency, with an amplitude of 50 to 2,000 mA and a pulse frequency of 30 Hz for 25 minutes per session.
Number of subjects: 42
Study 18401195 — intervention group
Group type: COMPARATOR
Intervention: Placebo stimulation (no actual electrical stimulus given).
Number of subjects: 42
Study 16085200 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated mailing of the questionnaire
Number of subjects: 955
Study 16085200 — intervention group
Group type: COMPARATOR
Intervention: Simple reminder card
Number of subjects: 955
Study 16085200 — intervention group
Group type: COMPARATOR
Intervention: Request to explain nonparticipation
Number of subjects: 955
Study 12874583 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenum-preserving pancreatic head resection (DPPHR)
Number of subjects: 70
Study 12874583 — intervention group
Group type: COMPARATOR
Intervention: Classic pancreatoduodenectomy (PD)
Number of subjects: 70
Study 10472872 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol
Number of subjects: 91
Study 10472872 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 8567299 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid-filled circulating blanket (active-conductive external rewarming)
Number of subjects: 32
Study 8567299 — intervention group
Group type: COMPARATOR
Intervention: Reflective blanket (passive-reflective external rewarming)
Number of subjects: 32
Study 1784499 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.075% capsaicin cream applied 4 times/day for 6 weeks
Number of subjects: 0
Study 1784499 — intervention group
Group type: COMPARATOR
Intervention: Vehicle cream (control) applied to the other forearm
Number of subjects: 0
Study 6127542 — intervention group
Group type: EXPERIMENTAL
Intervention: microencapsulated potassium chloride formulation
Number of subjects: 48
Study 6127542 — intervention group
Group type: COMPARATOR
Intervention: wax-matrix formulation
Number of subjects: 48
Study 6127542 — intervention group
Group type: EXPERIMENTAL
Intervention: glycopyrrolate
Number of subjects: 48
Study 31623936 — intervention group
Group type: EXPERIMENTAL
Intervention: Methoxyflurane (up to 2×3 mL)
Number of subjects: 305
Study 31623936 — intervention group
Group type: COMPARATOR
Intervention: Standard analgesic treatment
Number of subjects: 305
Study 31623936 — intervention group
Group type: EXPERIMENTAL
Intervention: Methoxyflurane
Number of subjects: 305
Study 31292955 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal ultrasound biometry
Number of subjects: 845
Study 31292955 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal ultrasound measure
Number of subjects: 845
Study 31292955 — intervention group
Group type: EXPERIMENTAL
Intervention: Subscapular fat mass in the fetus and the newborn
Number of subjects: 845
Study 31292955 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal fat mass (AFM) measurements
Number of subjects: 845
Study 29079478 — intervention group
Group type: EXPERIMENTAL
Intervention: Lunch is in the Bag intervention
Number of subjects: 633
Study 29079478 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 633
Study 26794137 — intervention group
Group type: EXPERIMENTAL
Intervention: Bezafibrate 400 mg/day
Number of subjects: 3090
Study 26794137 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3090
Study 25223711 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh pomegranate juice (PJ), 1.5 mL per kg body weight
Number of subjects: 85
Study 22773261 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐Leg (Otto Bock)
Number of subjects: 12
Study 22773261 — intervention group
Group type: EXPERIMENTAL
Intervention: SNS (CaTech)
Number of subjects: 12
Study 22773261 — intervention group
Group type: EXPERIMENTAL
Intervention: 3R60 (Otto Bock)
Number of subjects: 12
Study 22773261 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐Leg (Otto Bock) with MLT
Number of subjects: 12
Study 22773261 — intervention group
Group type: EXPERIMENTAL
Intervention: SNS (CaTech) with MLT
Number of subjects: 12
Study 22773261 — intervention group
Group type: EXPERIMENTAL
Intervention: 3R60 (Otto Bock) with MLT
Number of subjects: 12
Study 20304867 — intervention group
Group type: EXPERIMENTAL
Intervention: High fibrinogen levels
Number of subjects: 111
Study 20304867 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated fibrinogen levels
Number of subjects: 111
Study 20304867 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated fibrinogen levels with angiographic progression or nonregression
Number of subjects: 111
Study 18053393 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers (atenolol 100 mg id for five consecutive days)
Number of subjects: 10
Study 18053393 — intervention group
Group type: COMPARATOR
Intervention: No beta-blockers
Number of subjects: 10
Study 18053393 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 10
Study 16075416 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 60
Study 16075416 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 60
Study 16075416 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin and Atorvastatin
Number of subjects: 60
Study 12131435 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic fixation
Number of subjects: 52
Study 12131435 — intervention group
Group type: COMPARATOR
Intervention: Static fixation
Number of subjects: 52
Study 10229887 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer Assessment Rating (PAR) index treatment
Number of subjects: 103
Study 8561152 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy (tetracycline 250 mg, metronidazole 250 mg, colloidal bismuth subcitrate 120 mg, four times daily for 14 days)
Number of subjects: 118
Study 8561152 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin (1000 mg) and omeprazole (40 mg) both twice daily for 14 days
Number of subjects: 118
Study 8561152 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy
Number of subjects: 118
Study 8561152 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin/omeprazole
Number of subjects: 118
Study 1811640 — intervention group
Group type: EXPERIMENTAL
Intervention: Fittydent
Number of subjects: 32
Study 1811640 — intervention group
Group type: EXPERIMENTAL
Intervention: Super Poligrip
Number of subjects: 32
Study 1811640 — intervention group
Group type: EXPERIMENTAL
Intervention: Super Wernet's
Number of subjects: 32
Study 1811640 — intervention group
Group type: EXPERIMENTAL
Intervention: tragacanth
Number of subjects: 32
Study 6882885 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinidine administered with food
Number of subjects: 9
Study 6882885 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinidine administered with antacid
Number of subjects: 9
Study 6882885 — intervention group
Group type: COMPARATOR
Intervention: Quinidine administered in fasting state
Number of subjects: 9
Study 31175564 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescent family-centered intervention
Number of subjects: 463
Study 31175564 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 463
Study 29250772 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 4 mg
Number of subjects: 710
Study 29250772 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 8 mg
Number of subjects: 710
Study 29250772 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 12 mg
Number of subjects: 710
Study 29250772 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 710
Study 26573488 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted implementation strategy for the prevention of hand eczema
Number of subjects: 1649
Study 26573488 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1649
Study 25041789 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring-plus-reinforcement-thinning condition
Number of subjects: 77
Study 25041789 — intervention group
Group type: COMPARATOR
Intervention: Monitoring-only condition
Number of subjects: 77
Study 22228043 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin (4 mg/day)
Number of subjects: 79
Study 22228043 — intervention group
Group type: COMPARATOR
Intervention: No doxazosin (control group)
Number of subjects: 79
Study 20368567 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab added to cyclophosphamide, doxorubicin, vincristine, and prednisone induction treatment
Number of subjects: 465
Study 20368567 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab maintenance
Number of subjects: 465
Study 20368567 — intervention group
Group type: EXPERIMENTAL
Intervention: BCL2/IgH levels at the end of induction treatment
Number of subjects: 465
Study 20368567 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretreatment positive BM results
Number of subjects: 465
Study 17347577 — intervention group
Group type: EXPERIMENTAL
Intervention: Cellulosic membrane
Number of subjects: 0
Study 17347577 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic membrane
Number of subjects: 0
Study 17347577 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 0
Study 15736262 — intervention group
Group type: EXPERIMENTAL
Intervention: Inoue balloon (IB) technique
Number of subjects: 50
Study 15736262 — intervention group
Group type: COMPARATOR
Intervention: Metallic commissurotome (MC) technique
Number of subjects: 50
Study 11862508 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft diet recommended after bowel surgery
Number of subjects: 0
Study 11862508 — intervention group
Group type: COMPARATOR
Intervention: High-fiber diet
Number of subjects: 0
Study 11277447 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed block condition (with both within- and across-trial variability information)
Number of subjects: 3
Study 11277447 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial-random condition (with within-trial variability information)
Number of subjects: 3
Study 11277447 — intervention group
Group type: COMPARATOR
Intervention: Full-random condition (with neither within- nor across-trial variability information)
Number of subjects: 3
Study 9735662 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific IgE (slgE) antibodies
Number of subjects: 42
Study 9735662 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific IgG4 (slgG4) antibodies
Number of subjects: 42
Study 9735662 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific IgG antibodies
Number of subjects: 42
Study 9735662 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific IgG4 antibodies
Number of subjects: 42
Study 9735662 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure duration
Number of subjects: 42
Study 8042449 — intervention group
Group type: EXPERIMENTAL
Intervention: Early surgical revision of the septic focus (Group 1, within 6 days, n = 15)
Number of subjects: 40
Study 8042449 — intervention group
Group type: COMPARATOR
Intervention: Late surgery (Group 2, later than 6 days, n = 19)
Number of subjects: 40
Study 8042449 — intervention group
Group type: COMPARATOR
Intervention: No surgery at all (Group 3, n = 6)
Number of subjects: 40
Study 2759066 — intervention group
Group type: COMPARATOR
Intervention: 30% oxygen
Number of subjects: 0
Study 2759066 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% oxygen
Number of subjects: 0
Study 1099048 — intervention group
Group type: EXPERIMENTAL
Intervention: Doctor's Choice (DC) method of administering psychotropic drugs
Number of subjects: 0
Study 1099048 — intervention group
Group type: COMPARATOR
Intervention: Thioridazine (100 to 900 mg)
Number of subjects: 0
Study 1099048 — intervention group
Group type: COMPARATOR
Intervention: Chlordiazepoxide (30 mg)
Number of subjects: 0
Study 1099048 — intervention group
Group type: COMPARATOR
Intervention: Imipramine (75 mg)
Number of subjects: 0
Study 396656 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine (PRZ) 150 mg daily
Number of subjects: 30
Study 396656 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine (PRZ)
Number of subjects: 30
Study 396656 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 30
Study 31210636 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey of parents' knowledge and experiences with LVAS
Number of subjects: 100
Study 31210636 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey of audiologists' knowledge and experiences with LVAS
Number of subjects: 100
Study 31210636 — intervention group
Group type: EXPERIMENTAL
Intervention: Interest in continuing education about LVAS
Number of subjects: 100
Study 29034602 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol alone (G-1)
Number of subjects: 170
Study 29034602 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Ibuprofen/Paracetamol (G-2)
Number of subjects: 170
Study 29034602 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Mefenamic acid/Paracetamol (G-3)
Number of subjects: 170
Study 29034602 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Diclofenac K/Paracetamol (G-4)
Number of subjects: 170
Study 29034602 — intervention group
Group type: COMPARATOR
Intervention: Placebo (G-5)
Number of subjects: 170
Study 27317708 — intervention group
Group type: EXPERIMENTAL
Intervention: Comic information leaflet (delivered at home in addition to routine information)
Number of subjects: 115
Study 27317708 — intervention group
Group type: COMPARATOR
Intervention: Routine information only (control group)
Number of subjects: 115
Study 24770560 — intervention group
Group type: EXPERIMENTAL
Intervention: Wireless, portable vital signs monitor (WVSM)
Number of subjects: 305
Study 24770560 — intervention group
Group type: COMPARATOR
Intervention: Standard monitor (control)
Number of subjects: 305
Study 24770560 — intervention group
Group type: EXPERIMENTAL
Intervention: Both WVSM and standard monitor
Number of subjects: 305
Study 22521148 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine hydrochloride (0.5 mg/kg)
Number of subjects: 20
Study 20609991 — intervention group
Group type: EXPERIMENTAL
Intervention: Local intra-arterial fibrinolysis (LIF) using recombinant tissue plasminogen activator (rtPA)
Number of subjects: 84
Study 20609991 — intervention group
Group type: COMPARATOR
Intervention: Conservative standard treatment (CST)
Number of subjects: 84
Study 18047883 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic blind subjects
Number of subjects: 29
Study 18047883 — intervention group
Group type: COMPARATOR
Intervention: Nondiabetic blind subjects
Number of subjects: 29
Study 18047883 — intervention group
Group type: COMPARATOR
Intervention: Blindfolded sighted volunteers
Number of subjects: 29
Study 16315646 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct-likelihood methods
Number of subjects: 0
Study 16315646 — intervention group
Group type: COMPARATOR
Intervention: Complete case analysis (CC)
Number of subjects: 0
Study 16315646 — intervention group
Group type: COMPARATOR
Intervention: Last observation carried forward (LOCF)
Number of subjects: 0
Study 16315646 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple imputation
Number of subjects: 0
Study 16315646 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectation-maximization algorithm
Number of subjects: 0